Abemaciclib
Jump to navigation
Jump to search
| Abemaciclib | |
|---|---|
| Term | Abemaciclib |
| Short definition | abemaciclib (uh-BEH-muh-SY-klib) medicine used alone or with other medicines to treat adults with certain types of hormone receptor-positive, HER2-negative breast cancer. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
abemaciclib - (pronounced) (uh-BEH-muh-SY-klib) medicine used alone or with other medicines to treat adults with certain types of hormone receptor-positive, HER2-negative breast cancer. It is also being studied in the treatment of other types of cancer. Abemaciclib blocks certain proteins that can prevent cancer cells from growing. It is a type of cyclin-dependent kinase inhibitor. Also called Verzenio
External links
- Medical encyclopedia article on Abemaciclib
- Wikipedia's article - Abemaciclib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski